Novel phospholipid-based drug formulation retards the 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.

Typeset version

 

TY  - CONF
  - Fisher, A., Harris, D.M., Harkin, A.J., Bolton, A.E., Sullivan, A.M., Nolan Y.M.
  - Society for Neuroscience Meeting, San Diego, USA.
  - Novel phospholipid-based drug formulation retards the 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.
  - San Diego, USA.
  - Invited Lectures (Conference)
  - 2004
  - ()
  - 0
DA  - 2004/NaN
ER  - 
@unpublished{V273775347,
   = {Fisher,  A. and  Harris,  D.M. and  Harkin,  A.J. and  Bolton,  A.E. and  Sullivan,  A.M. and  Nolan Y.M. },
   = {Society for Neuroscience Meeting, San Diego, USA.},
   = {{Novel phospholipid-based drug formulation retards the 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.}},
   = {San Diego, USA.},
   = {Invited Lectures (Conference)},
   = {2004},
   = {()},
   = {0},
  source = {IRIS}
}
AUTHORSFisher, A., Harris, D.M., Harkin, A.J., Bolton, A.E., Sullivan, A.M., Nolan Y.M.
TITLESociety for Neuroscience Meeting, San Diego, USA.
PUBLICATION_NAMENovel phospholipid-based drug formulation retards the 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.
LOCATIONSan Diego, USA.
CONFERENCE_TYPEInvited Lectures (Conference)
YEAR2004
TIMES_CITED()
PEER_REVIEW0
START_DATE
END_DATE
ABSTRACT
FUNDED_BY